GIPR
Generation Income Properties Inc
Mentions (24Hr)
0.00% Today
Reddit Posts
GIPR I believe needs just little push lots of good news in my opinion plus I can not get the share float out of my head 1million shares float 🙏🙏🤞🤞
GIPR looks interesting, 1mil share float resent IPO can maybe squeeze hard 🤔🤞!!!!
Mentions
GIPR looks tasty for rate cuts trading only 1x revenue
Why do the stocks that come up on my screener never consist of whats being pushed here? Webull screener; Region: United States Last price: $0-2 Volume: 5 million and up Free float: 10 million and under CHR WORX PALI GIPR EZGO BLMZ BENF
Next week I’m looking forward to RVPH continuing its move to a buck, GIPR continuing its move and IVDA recovering. NUAI is going to form a base around this level and realistically institutions have no reason to push it higher. Its catalyst will be the deal announcement, can scalp it short term or go medium here.
Loving the volume and interest on GIPR, any DD or catalyst?
Thank you GIPR sama for saving me.
IVDA and NUAI down on barely any volume yea totally not manipulated. GIPR offsetting losses though
Was looking to play CHR on the day, but Fidelity doesn't allow online orders for it. Pivoting to IMG instead. Popping up in a lot of circles alongside BURU, GIPR, CHR and others.
GIPR looking yummy. Think it wants 5-6.
keep an eye on GIPR. There's resistance at 0.95 if it breaks that and the $1 there could potentially be a short squeeze
Thanks for the quick summary dude (or dudet)...I will need to take a look later tonight. PFE is certainly undervalued and the reason for warranted. GLPs are all the rage lol, but I have read only in brief on GIPR.
Well, as Albert said, it's not about the top line growth for now, due to the loss of exclusivity (Eliquis being a notable example). It's all about EPS growth. Our [pipeline](https://www.pfizer.com/science/drug-product-pipeline) is smaller. Danu got discontinued. But our leadership hasn't given up on obesity just yet. There's a very interesting GIPR antagonist molecule in phase 2, PF-07976016. That one's different from the well-know, very hype-y, GLP molecules.
Eli Lilly bb. They have a tri-agonist in development against GLP1R, GIPR, and GCGR called Retatruside. It’s basically Tirzepatide (Mounjaro or Zepbound) on steroids. And Tirzepatide is Ozempic on steroids. This, along with other assets in their pipeline targeting diabetes, obesity, and inflammation…Lilly has a lot of room to grow.
Thinking about buying GIPR, PSEC, and AGNC. what do you think of them and do you think they will go up.
I have a couple dividend stocks GIPR , VALE , , GOLD
GIPR - 400% runner today mark my words